Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PPLBTC

(PPLBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/03/202411:35AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesEU:VLAValneva SE
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesTG:AYJValneva SE
06/03/202411:35AMGlobeNewswire Inc.Programme de rachat d'actions propres - Déclaration des transactions sur actions propres réalisées du 27 mai 2024 au 31 mai 2024LSE:0OA7Assystem Sa
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesEU:VLAValneva SE
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesVLAP
06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesLSE:0OB3Valneva Se
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesLSE:0OB3Valneva Se
06/03/202411:35AMGlobeNewswire Inc.Programme de rachat d'actions propres - Déclaration des transactions sur actions propres réalisées du 27 mai 2024 au 31 mai 2024EU:ASYAssystem
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesTG:AYJValneva SE
06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesEU:VLAValneva SE
06/03/202411:34AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JLLJones Lang LaSalle Inc
06/03/202411:34AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:34AMGlobeNewswire Inc.WENDEL : Déclaration des opérations de rachat d'actions réalisées au 31 mai 2024TG:WISWendel SA
06/03/202411:34AMGlobeNewswire Inc.WENDEL : Déclaration des opérations de rachat d'actions réalisées au 31 mai 2024EU:MFWendel SA
06/03/202411:34AMPR Newswire (Canada)Canada at the forefront of international research on climate change adaptation and mitigation
06/03/202411:34AMPR Newswire (Canada)Le Canada à l'avant-garde de la recherche sur l'adaptation aux changements climatiques et l'atténuation de leurs effets
06/03/202411:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BRIPFBrookfield Infrastructure Partners LP (PK)
06/03/202411:33AMPR Newswire (US)FiiZ Celebrates 10 Years of Success with Free Drinks and 10 Chances at Free FiiZ for a Year
06/03/202411:33AMGlobeNewswire Inc.Natiivo Hospitality Expands with New South Florida Projects, Hires Yoav Gery as President
06/03/202411:32AMPR Newswire (US)Global Health & Medical Insurance Market Set to Surge to $3.4 Trillion by 2028
06/03/202411:31AMAlliance NewsAlliance NewsTOP NEWS: Data shows opposing views as to state of US manufacturing
06/03/202411:31AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JLLJones Lang LaSalle Inc
06/03/202411:31AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
06/03/202411:30AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
06/03/202411:30AMGlobeNewswire Inc.Déclaration hebdomadaire rachat d'actions du 27 au 31 mai 2024LSE:0A8ATechnip Energies Nv
06/03/202411:30AMGlobeNewswire Inc.Déclaration hebdomadaire rachat d'actions du 27 au 31 mai 2024EU:TETechnip Energies NV
06/03/202411:30AMGlobeNewswire Inc.Titan.ium Platform Announces Collaboration with Nokia Improving Security for Global Telecommunications Networks
06/03/202411:30AMBusiness WireShionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats
06/03/202411:30AMGlobeNewswire Inc.Weekly report share buyback from May 27 to May 31, 2024LSE:0A8ATechnip Energies Nv